联康生物科技集团宣布将加强在皮肤科、眼科、代谢疾病及其他关键治疗领域的研发合作。此次战略布局旨在通过整合内外部资源,提升创新药物研发效率,进一步拓展公司在专科治疗市场的竞争力。合作将聚焦前沿生物技术转化,加速具有临床价值的新药从实验室走向市场。
联康生物科技集团宣布将加强在皮肤科、眼科、代谢疾病及其他关键治疗领域的研发合作。此次战略布局旨在通过整合内外部资源,提升创新药物研发效率,进一步拓展公司在专科治疗市场的竞争力。合作将聚焦前沿生物技术转化,加速具有临床价值的新药从实验室走向市场。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.